Kisunla BRAND Launch
branded and unbranded work
Since April 2022, I’ve been working on launching Lilly’s groundbreaking new Alzheimer’s medication, Kisunla (donanemab).
I mostly worked on drafting brand claims–copy that needs to be pre-approved for use in branded and unbranded tactics.
When launch day came in early July 2024, we were ready.
TACTICS COMING SOON
In the meantime, you can check out the branded and unbranded websites I worked on for Lilly Alzheimer’s and Kisunla.
Kisunla website: https://kisunla.lilly.com
Disease Education (DSE) website: https://morethannormalaging.lilly.com